迈普医学：拟使用4亿元闲置自有资金购买理财产品

Core Viewpoint - The company plans to use up to 400 million yuan of idle funds to purchase safe and liquid financial products, subject to shareholder approval [1] Group 1 - The proposed investment amount is capped at 400 million yuan [1] - The investment will be made in financial products characterized by high safety and good liquidity [1] - The approval for this investment has been granted by the company's third board meeting and is pending shareholder meeting approval [1]